CHICAGO, June 17,
2024 /PRNewswire/ -- The membrane chromatography
market is poised to grow significantly, with a projected value of
USD 637 million by 2029, reflecting a
robust CAGR of 14.7% from an estimated USD
321 million in 2024. This growth is primarily fueled by the
escalating production of biopharmaceuticals like vaccines and
monoclonal antibodies, coupled with increased R&D activities in
the biopharmaceutical sector. Key players in this market include
Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific Inc.
(US), who employ strategies such as new product launches,
acquisitions, agreements, collaborations, and geographical
expansions to bolster their market presence. Danaher Corporation is
known for its extensive range of life science and diagnostic
products, investing heavily in R&D, while Sartorius AG stands
out for its global reach and strategic collaborations like the one
with Waters Corporation for downstream biomanufacturing. Merck
KGaA, on the other hand, is recognized for its comprehensive
solutions and ongoing investments in R&D, as demonstrated by
its substantial investment in membrane and filtration manufacturing
capabilities in Cork, Ireland.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196
Browse in-depth TOC on "Membrane Chromatography
Market"
416 - Tables
52 -
Figures
348 - Pages
DRIVER: Catalyzing Growth Through Increased Biopharmaceutical
R&D
As C-level executives, you're aware of the pivotal role R&D
plays in the biopharmaceutical sector, especially amidst the
escalating demand for treatments targeting chronic illnesses. The
robust increase in R&D investments, exemplified by a
significant uptick in spending among Spanish biotech firms in 2022,
underscores the driving force behind the membrane chromatography
market's expansion.
RESTRAINT: Slow Adoption in Large-Scale Manufacturing
Despite its promising advantages, membrane chromatography
encounters obstacles when it comes to scaling up for large-scale
operations. Challenges such as membrane degradation and fouling,
coupled with the entrenched dominance of traditional column
chromatography, impede widespread adoption. These complexities,
alongside the risks of process disruption and quality compromises,
restrain the market's growth within large-scale manufacturing.
OPPORTUNITY: Embracing Single-Use Technologies for Enhanced
Efficiency
The shift towards single-use membrane chromatography systems
presents a compelling opportunity for executives seeking efficiency
gains. These systems offer tangible benefits, including reduced
contamination risks and lower capital investments. Collaborative
efforts, like the partnership between W. L. Gore & Associates,
Inc. and AGC Biologics, signal a strategic move towards
streamlining downstream purification processes and maximizing
productivity.
CHALLENGE: Competing with Alternative Techniques
In the landscape of membrane chromatography, executives must
navigate the challenge posed by alternative techniques such as
protein crystallization and capillary electrophoresis. These
methods, renowned for their simplicity and cost-effectiveness,
present formidable competition, potentially diverting market focus
from membrane chromatography solutions and posing a significant
hurdle to its sustained growth.
Global Membrane Chromatography Industry Ecosystem
Analysis
Executives operating within the membrane chromatography industry
are part of a multifaceted ecosystem encompassing raw material
suppliers, manufacturers, and end users ranging from pharmaceutical
giants to academic institutions. Product portfolios span from
essential syringe filters to advanced membrane sheets, catering to
diverse needs across the sector's spectrum.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=151487196
Flow-Through Membrane Chromatography Leads Industry Growth in
2023
The dominance of flow-through membrane chromatography in 2023
underscores a strategic focus on biologics development,
particularly monoclonal antibodies. The segment's ascendancy is
further fueled by the industry's quest for efficient chromatography
operations, positioning it as a key driver in the membrane
chromatography market.
Pharmaceutical & Biopharmaceutical Companies Drive Market
Growth
In 2023, pharmaceutical and biopharmaceutical companies emerged
as the dominant force within the membrane chromatography landscape,
buoyed by the escalating demand for biotherapeutics. The segment's
robust growth trajectory is propelled by increased R&D
investments aimed at advancing biopharmaceutical products,
solidifying its pivotal role in the membrane chromatography
market.
North America Commands Membrane Chromatography Market in
2023
North America's commanding
presence in the membrane chromatography market during 2023
underscores its status as a key hub for biopharmaceutical
development and manufacturing. With significant investments in
R&D and a well-established healthcare sector, North America leads the global market,
followed closely by Europe and the
Asia Pacific, reflecting the
region's pivotal role in driving industry innovation and
growth.
Recent Innovations Shape Membrane Chromatography Landscape
- Thermo Fisher Scientific Inc. Enhances Presence in
Asia Pacific with New
Facility
In February 2024,
Thermo Fisher Scientific Inc. fortified its position in the
Asia Pacific market with the
inauguration of a sterile drug facility in Singapore. This strategic investment aligns
with the company's commitment to delivering new medicines and
vaccines, complementing enhanced research capabilities at its
Customer Experience Center and Bioprocess Design Center. The
Customer Experience Center, equipped with a wide array of products
spanning molecular biology, genetic analysis sequencing,
chromatography mass spectrometry, and cell therapy, underscores
Thermo Fisher Scientific's dedication to innovation and
customer-centric solutions.
- Agilent Technologies Invests in Nucleic Acid Therapeutics
Manufacturing
January 2023
witnessed Agilent Technologies' significant investment of
USD 725 million to expand its
manufacturing capacity for nucleic acid-based therapeutics. This
expansion underscores Agilent's commitment to meeting the growing
demand for advanced therapeutics, positioning the company as a key
player in the evolving landscape of nucleic acid-based
treatments.
- Sartorius AG Expands Portfolio Through Novasep
Acquisition
In February 2022,
Sartorius AG bolstered its chromatography capabilities with the
acquisition of Novasep's chromatography division. This strategic
move enables Sartorius to access a portfolio tailored for smaller
biomolecules like oligonucleotides, peptides, and insulin, as well
as innovative systems for continuous biologics manufacturing. By
integrating Novasep's offerings, Sartorius aims to diversify its
revenue streams and strengthen its position as a leading provider
of chromatography solutions.
- 3M Introduces Breakthrough
Solution for Protein Therapeutic Manufacturing
June 2021 marked the launch of 3M Harvest RC clarifier, a revolutionary
single-stage purification solution designed for recombinant protein
therapeutic manufacturing. This innovation underscores 3M's
commitment to advancing bioprocessing technologies, offering a
streamlined and efficient solution for protein purification,
thereby enhancing manufacturing efficiency and product
quality.
For more information, inquire now! Inquire Now
Related Reports:
Chromatography Instruments Market
Chromatography Accessories & Consumables Market
High Performance Liquid Chromatography Market
Gas Chromatography Market
Life Science Instrumentation Market
Get access to the latest updates on Membrane Chromatography
Companies and Membrane Chromatography Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of
America's best management consulting firms by Forbes, as per
their recent report.
MarketsandMarkets™ is a blue ocean alternative in
growth consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/membrane-chromatography-market-to-reach-usd-637-million-with-14-7-cagr--marketsandmarkets-302172907.html
SOURCE MarketsandMarkets